DRUGS · SERVICE DETAILS

Continuous drug compliance and information maintenance

Combine information changes and follow-up maintenance in conjunction with the status of enterprise facilities, product listing, labels and technical documents; There is no default to include full declaration or quality system work.

Applicability and scope depend on the product, your business role and the agreed engagement. The service does not constitute FDA approval or certification.

SERVICE OVERVIEW

What does this service help with?

Combine information changes and follow-up maintenance in conjunction with the status of enterprise facilities, product listing, labels and technical documents; Without the default inclusion of a full declaration or quality system, we will first identify the specific matters to be addressed and the scope of collaboration, taking into account product categories and the applicability of current information.

WHO MAY NEED IT

Who should consider this service?

Pharmaceutical manufacturers, brands/labellers and businesses involved in United States drug registration or technology declarations need to be identified on a case-by-case basis in relation to product types, business activities, target markets and applicable regulations.

SCOPE & APPROACH

What we typically discuss

Identify information gaps before agreeing on documentation and responsibilities.

01

Confirm the product and business entity

Review product characteristics, responsible businesses and facilities, activities and existing records to select the appropriate process.

02

Review applicable requirements

Confirm requirements and open questions about registration, listing, documentation, labels or contact information relevant to the service.

03

Agree on the specific scope

Discuss required documents, responsibilities, timing and fees. The agreed scope governs the work.

GET READY

What to prepare before contacting us

If documents are incomplete, share the product and current stage first. You can provide the remaining details later.

  • Product category, formulation type, composition and intended use
  • Information on activities, labels and products of enterprises and facilities
  • Recorded registration, listing, declaration or technical document
HOW TO START

From initial review to engagement

STEP 01

Describe your current needs

Share the product, your role, target market and current stage.

STEP 02

Provide additional materials

Prepare relevant facility, product, technical or label records based on the service.

STEP 03

Confirm service arrangements

Define the applicable requirements, scope, documentation responsibilities and fees.

STEP 04

Proceed with the agreed work

Work within the confirmed scope and discuss applicable maintenance.

Registration, listing or submission of supporting information does not confer FDA approval, certification or marketing authorization. Refer to current FDA requirements and the facts of your project.

TIMING & FEES

Timing and fees

Information reviewed:Fee period: FY 2027, October 1, 2026 through September 30, 2027. For other charges, use the FDA rules as of the review date.

Timing and preparation

Document preparation

The agreed delivery plan is available and the scope is confirmed; The volume of products, technical information gaps, changing wheels and the speed of client feedback affect the lead time.

FDA processing

The annual facility renewal window is from 1 October to 31 December; Lists are updated in June and December, as applicable, and annual certification and other changes are processed.

Fee breakdown

FDA fees

Registration of general pharmaceutical facilities and submission of Drug Listing does not in and of itself charge a fee; This does not amount to a total FDA obligation for the enterprise to be free of charge. Depending on the actual drug and facility activity, additional user fees are available for GDUFA, OMUFA, PDUFA or other applicable user fees.

Service fees

Consulting and filing are quoted separately from FDA fees, based on the number of products, completeness of the records, work scope, response rounds and service term.

Other possible costs

Testing, translation, software and other third-party work are quoted separately where needed.

START WITH YOUR PRODUCT

Tell us about your product so we can discuss the appropriate pathway.

Share intended use, ingredients or technical characteristics, production location, business role and current stage. We can use this information to discuss likely FDA requirements and service scope.